Cannabinoids for the Reversal of Cognitive Impairments in Schozophrenia: Evaluating the Role of the Putative, Novel Cannabinoid Receptor GPR55 and the Temporoammonic Pathway (PhD Studentship) (Joint with University College Dublin and Industry)